NCT00004047View on ClinicalTrials.gov

Chemotherapy in Treating Patients Who Have Hematologic Cancer

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 1999

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions

LeukemiaMyelodysplastic Syndromes

Interventions

DRUG

exatecan mesylate

Trial Locations (1)

77030

University of Texas - MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY